| Secondary |
| Drug Use For Unknown Indication |
32.9% |
| Product Used For Unknown Indication |
17.7% |
| Asthma |
6.8% |
| Hypertension |
6.3% |
| Colorectal Cancer Metastatic |
4.1% |
| Depression |
4.1% |
| Pain |
3.5% |
| Rheumatoid Arthritis |
3.3% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Prophylaxis |
2.4% |
| Breast Cancer |
1.9% |
| Congenital Aplastic Anaemia |
1.9% |
| Constipation |
1.9% |
| Blood Pressure |
1.6% |
| Hallucination |
1.6% |
| Memory Impairment |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Analgesic Therapy |
1.4% |
| Bipolar Disorder |
1.4% |
| Convulsion |
1.4% |
|
| Completed Suicide |
11.8% |
| Pulmonary Embolism |
8.8% |
| Circumstance Or Information Capable Of Leading To Medication Error |
7.4% |
| Vomiting |
7.4% |
| Pyrexia |
5.9% |
| Thyroid Disorder |
5.9% |
| Diabetes Mellitus Inadequate Control |
4.4% |
| Hypotension |
4.4% |
| Intentional Overdose |
4.4% |
| Oedema Peripheral |
4.4% |
| Overdose |
4.4% |
| Rash |
4.4% |
| Renal Failure |
4.4% |
| Shock Haemorrhagic |
4.4% |
| Atrial Fibrillation |
2.9% |
| Blood Pressure Inadequately Controlled |
2.9% |
| Breast Cancer |
2.9% |
| Disease Progression |
2.9% |
| Drug Ineffective |
2.9% |
| Grand Mal Convulsion |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.0% |
| Product Used For Unknown Indication |
11.7% |
| Hypertension |
7.6% |
| Rheumatoid Arthritis |
7.2% |
| Asthma |
5.8% |
| Depression |
5.5% |
| Bipolar Disorder |
3.1% |
| Diabetes Mellitus |
3.1% |
| Migraine |
3.0% |
| Pain |
3.0% |
| Idiopathic Thrombocytopenic Purpura |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Hiv Infection |
2.2% |
| Restless Legs Syndrome |
2.1% |
| Blood Cholesterol Increased |
1.8% |
| Insomnia |
1.8% |
| Contraception |
1.8% |
| Breast Cancer |
1.7% |
| Benign Prostatic Hyperplasia |
1.7% |
| Constipation |
1.5% |
|
| Drug Ineffective |
11.3% |
| Rash |
11.0% |
| Vomiting |
9.1% |
| Death |
8.5% |
| Product Quality Issue |
7.0% |
| Nausea |
6.7% |
| Pain |
4.5% |
| Weight Increased |
4.5% |
| Myocardial Infarction |
4.2% |
| Weight Decreased |
3.9% |
| Somnolence |
3.7% |
| Pneumonia |
3.5% |
| Tremor |
3.2% |
| Pharmaceutical Product Complaint |
3.0% |
| Malaise |
2.9% |
| No Adverse Event |
2.7% |
| Urticaria |
2.7% |
| Convulsion |
2.6% |
| Diarrhoea |
2.5% |
| Oedema Peripheral |
2.5% |
|
| Interacting |
| Contraception |
42.9% |
| Product Used For Unknown Indication |
42.9% |
| Hyperlipidaemia |
14.3% |
|
| Nasopharyngitis |
25.0% |
| Oral Candidiasis |
25.0% |
| Pneumonia |
25.0% |
| Rhabdomyolysis |
25.0% |
|
